Search research articles
Contact Us
Filters
Showing results (101-110 of 108) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 108 results.
Clinical Chemistry and Laboratory Medicine
|
May 16, 2003
Which are the best tools for specific clinical application (chips, multiplex, mass spec profile, etc.)?
M Ferrari, G Michel, D Foernzler, et al.
Clinical Chemistry and Laboratory Medicine
|
May 16, 2003
Which, and how limited number of polymorphisms should be selected per disease, risk assessment, health profile or biological system?
L Masana, T Madan, S Visvikis, et al.
Genome Research
|
October 19, 1999
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
S Cheng, M A Grow, C Pallaud, et al.
Translational Psychiatry
|
March 8, 2017
VEGF-related polymorphisms identified by GWAS and risk for major depression
T Xie, M G Stathopoulou, F de Andrés, et al.
Clinical Chemistry and Laboratory Medicine
|
November 7, 1998
A multilocus genotyping assay for cardiovascular disease
S Cheng, C Pallaud, M A Grow, et al.
Atherosclerosis
|
September 22, 2000
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project
F Schiele, D De Bacquer, M Vincent-Viry, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 16, 2010
A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism
G Antoni, P-E Morange, Y Luo, et al.
Clinical Chemistry and Laboratory Medicine
|
November 9, 2000
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group
G Siest, P Bertrand, B Qin, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 108) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 108 results.
Clinical Chemistry and Laboratory Medicine
|
May 16, 2003
Which are the best tools for specific clinical application (chips, multiplex, mass spec profile, etc.)?
M Ferrari, G Michel, D Foernzler, et al.
Clinical Chemistry and Laboratory Medicine
|
May 16, 2003
Which, and how limited number of polymorphisms should be selected per disease, risk assessment, health profile or biological system?
L Masana, T Madan, S Visvikis, et al.
Genome Research
|
October 19, 1999
A multilocus genotyping assay for candidate markers of cardiovascular disease risk
S Cheng, M A Grow, C Pallaud, et al.
Translational Psychiatry
|
March 8, 2017
VEGF-related polymorphisms identified by GWAS and risk for major depression
T Xie, M G Stathopoulou, F de Andrés, et al.
Clinical Chemistry and Laboratory Medicine
|
November 7, 1998
A multilocus genotyping assay for cardiovascular disease
S Cheng, C Pallaud, M A Grow, et al.
Atherosclerosis
|
September 22, 2000
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project
F Schiele, D De Bacquer, M Vincent-Viry, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 16, 2010
A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism
G Antoni, P-E Morange, Y Luo, et al.
Clinical Chemistry and Laboratory Medicine
|
November 9, 2000
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group
G Siest, P Bertrand, B Qin, et al.
Page
of 11